Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Cardiovascular Scores, Indexes, And Algorithms
Interactive worksheet6 clinical inputsPatient data not stored

PARADIGM-HF Responder Index (AWARD-Class) Calculator

AWARD-Class / PARADIGM-HF Responder context and interpretation The AWARD-Class score (derived from a two-center real-world cohort) is an easy-to-calculate index intended to predict a 1-year “super-response” to sacubitril/valsartan, defined in the derivation study as absence of HF admission/transplant/death plus either ≥50% NT-proBNP reduction and/or ≥10-point increase in LVEF. The score uses six routinely available c

Interactive worksheet

Clinical inputs

0/6 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

AWARD-Class / PARADIGM-HF Responder context and interpretation The AWARD-Class score (derived from a two-center real-world cohort) is an easy-to-calculate index intended to predict a 1-year “super-response” to sacubitril/valsartan, defined in the derivation study as absence of HF admission/transplant/death plus either ≥50% NT-proBNP reduction and/or ≥10-point increase in LVEF. The score uses six routinely available clinical variables (MRA use, sex, recent HF admission, ECG rhythm, diuretics use, and NYHA class) and maps the summed points to three probability groups (low, intermediate, high). Use this tool as an adjunct to clinical judgment — it was derived from an observational cohort and has not replaced randomized evidence.

Evidence & references2 primary sources mapped
  1. Source 1

    Moliner-Abós C, Rivas-Lasarte M, Pamies Besora J, et al. “A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure.” Cardiovasc Drugs Ther.

  2. Source 2

    (AWARD-Class score table and categories). For original randomized evidence on sacubitril/valsartan (PARADIGM-HF), see McMurray JJV et al., NEJM 2014.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

REHAB-HF Functional Recovery Index Calculator

Cardiovascular Scores, Indexes, And Algorithms
Interactive worksheet

GWTG-HF Length of Stay (LOS) Prediction Calculator

Cardiovascular Scores, Indexes, And Algorithms
Interactive worksheet

FINGER-HF Prognostic Tool

Cardiovascular Scores, Indexes, And Algorithms
Interactive worksheet

PROLONG Study ICD Monitoring Algorithm

Cardiovascular Scores, Indexes, And Algorithms
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.